Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder

Anesthesiology

Volumn 94, Issue 3, 2001, Pages 507-513

  Farquhar Smith, W P ^a   Rice, A S C ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; NERVE GROWTH FACTOR; PALMIDROL; RIMONABANT; TURPENTINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLADDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG RECEPTOR BINDING; FEMALE; FORELIMB; HYPERALGESIA; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; VISCERAL PAIN;

EID: 0035089509     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200103000-00023     Document Type: Article

References (39)

1. Are there fundamental differences in the peripheral mechanisms of visceral and somatic pain?
2. Recent and forgotten aspects of visceral pain
3. Effects of extracorporeal shock-wave lithotripsy on referred hyperalgesia from renal/ureteral calculosis
4. The role of nerve growth factor in a model of visceral inflammation
5. Inflammation of the rat urinary bladder is associated with a referred hyperalgesia which is NGF dependent
6. The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
7. Sensitisation of visceral afferents by nerve growth factor in the adult rat
8. Neuronal and behavioural consequences of chemical inflammarion of rat urinary bladder
9. Dermatomes in the rat limbs as determined by antidromic stimulation of sensory C-fibres in spinal nerves
10. Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat
11. Increased c-fos expression in spinal lumbosacral projection neurons and preganglionic neurons after irritation of the lower urinary tract in the rat
12. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
13. Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder
14. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis
15. Expression and coexpression of trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets
16. trkA, CGRP and IB4 expression In retrogradely labelled cutaneous and visceral primary sensory neurones in the rat
17. Mechanisms of referred visceral pain: Uterine inflammation in the adult virgin rat results in neurogenic plasma extravasation in the skin
18. Expression of c-Fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular and visceral stimulation
19. Two groups of spinal interneurones that respond to stimulation of the abdominal viscera of the cat
20. Visceral pain
21. Control of pain initiation by endogenous cannabinoids
22. Carmabinoids reduce hyperalgesia and inflammation via interaction with peripheral CBI receptors
23. Evidence for the presence of cannabinoid CBI receptors in mouse urinary bladder
24. Identification of genes differentially expressed by nerve growth factor and neurotrophin-3-dependent sensory neurones
25. Cannabinoid receptors undergo axonal flow in sensory nerves
26. Localization of central cannabinoid CBI receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridisation study
27. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2
28. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A
29. Antihyperalgesic effects of spinal cannabinoids
30. Spinal and supraspinal components of cannabinoid-induced antinociception
31. Cannabinoid CBI receptor expression in rat spinal cord
32. An analgesia circuit activated by cannabinoids
33. Activation of bladder mast cells in interstitial cystitis
34. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
35. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamide or anandamide is the physiological ligand for the cannabinoid CB2 receptor: Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
36. "Endocannabinoids" and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance
37. The palmitoylethanolamide and oleamide enigmas: Are these two fatty acid amides cannabimimetic?